Loading...

Integra LifeSciences Holdings Corporation

IARTNASDAQ
Healthcare
Medical - Devices
$12.27
$0.00(0.00%)

Integra LifeSciences Holdings Corporation (IART) Stock Overview

Explore Integra LifeSciences Holdings Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.3/100

Key Financials

Market Cap1B
P/E Ratio-34.88
EPS (TTM)$-0.38
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 Week$12.87
1 Month$12.55
3 Months$10.46
1 Year Target$16.55

IART Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Integra LifeSciences Holdings Corporation (IART) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $16.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -34.88 and a market capitalization of 1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
4.47%
4.47%
Profit Growth
$-0.38
110.25%
EPS Growth
$-0.38
110.37%
Operating Margin
2.91%
74.53%
ROE
-2.52%
110.25%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
0
Hold
0
Sell
1
Strong Sell
0

Price Targets

Low$20.00
Average$24.60
High$32.00

Company Profile

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

CEO

Mojdeh Poul

Employees

4,396

Headquarters

1100 Campus Road, Princeton, NJ

Founded

1995

Frequently Asked Questions

;